Novonesis A/S (OTC:NVZMY) Receives Sell Rating from Citigroup

Novonesis A/S (OTC:NVZMY)‘s stock had its “sell” rating reissued by investment analysts at Citigroup in a research note issued to investors on Thursday, StockNewsAPI reports.

Novonesis A/S Price Performance

OTC NVZMY traded down $1.13 on Thursday, reaching $67.00. 6,871 shares of the stock traded hands.

About Novonesis A/S

Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.